| Primary |
| Drug Use For Unknown Indication |
41.0% |
| Product Used For Unknown Indication |
15.3% |
| Pain |
11.4% |
| Drug Abuse |
6.0% |
| Cancer Pain |
5.4% |
| Back Pain |
3.7% |
| Idiopathic Pulmonary Fibrosis |
2.7% |
| Drug Abuser |
2.3% |
| Musculoskeletal Pain |
1.4% |
| Foetal Exposure During Pregnancy |
1.2% |
| Dyspnoea |
1.1% |
| Hypertension |
1.1% |
| Prophylaxis |
1.1% |
| Anxiety |
1.0% |
| Bone Pain |
1.0% |
| Depression |
1.0% |
| Neck Pain |
1.0% |
| Analgesic Therapy |
0.8% |
| Arthralgia |
0.8% |
| Myositis |
0.8% |
|
| Respiratory Arrest |
22.9% |
| Drug Hypersensitivity |
12.8% |
| Drug Abuse |
10.7% |
| Substance Abuse |
7.7% |
| Completed Suicide |
5.3% |
| Death |
5.3% |
| Toxicity To Various Agents |
5.1% |
| Cardiac Arrest |
4.3% |
| Drug Ineffective |
2.9% |
| Overdose |
2.9% |
| Somnolence |
2.9% |
| Road Traffic Accident |
2.7% |
| Delirium |
2.4% |
| Lung Neoplasm Malignant |
2.1% |
| Vomiting |
2.1% |
| Constipation |
1.6% |
| Pain |
1.6% |
| Serotonin Syndrome |
1.6% |
| Victim Of Homicide |
1.6% |
| Drug Dependence |
1.3% |
|
| Secondary |
| Pain |
20.2% |
| Product Used For Unknown Indication |
17.7% |
| Drug Use For Unknown Indication |
12.5% |
| Cancer Pain |
9.4% |
| Back Pain |
5.1% |
| Prophylaxis |
4.0% |
| Hypertension |
3.6% |
| Fibromyalgia |
3.2% |
| Adenocarcinoma Pancreas |
2.5% |
| Depression |
2.5% |
| Idiopathic Pulmonary Fibrosis |
2.3% |
| Constipation |
2.1% |
| Multiple Myeloma |
2.1% |
| Analgesic Therapy |
2.0% |
| Anxiety |
1.8% |
| Bone Pain |
1.8% |
| Metastatic Renal Cell Carcinoma |
1.8% |
| Osteoarthritis |
1.8% |
| Neuralgia |
1.7% |
| Neuropathy Peripheral |
1.5% |
|
| Drug Hypersensitivity |
13.4% |
| Vomiting |
7.9% |
| Toxicity To Various Agents |
7.5% |
| Delirium |
6.8% |
| Completed Suicide |
6.2% |
| Overdose |
6.2% |
| Pain |
6.2% |
| Respiratory Arrest |
6.2% |
| Drug Abuse |
5.8% |
| Somnolence |
4.5% |
| Death |
3.8% |
| Drug Ineffective |
3.4% |
| Pneumatosis Intestinalis |
3.1% |
| Weight Decreased |
3.1% |
| Weight Increased |
3.1% |
| Off Label Use |
2.7% |
| Substance Abuse |
2.7% |
| White Blood Cell Count Decreased |
2.7% |
| Decreased Appetite |
2.4% |
| Malaise |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
32.3% |
| Pain |
10.7% |
| Drug Use For Unknown Indication |
10.4% |
| Prophylaxis |
6.9% |
| Constipation |
4.3% |
| Hypertension |
4.1% |
| Cancer Pain |
3.7% |
| Nausea |
3.5% |
| Rheumatoid Arthritis |
3.4% |
| Anxiety |
2.6% |
| Back Pain |
2.3% |
| Diabetes Mellitus |
2.3% |
| Hiv Infection |
2.0% |
| Depression |
1.9% |
| Insomnia |
1.8% |
| Infection Prophylaxis |
1.8% |
| Colorectal Cancer Metastatic |
1.7% |
| Non-small Cell Lung Cancer |
1.6% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Renal Cell Carcinoma |
1.3% |
|
| Vomiting |
11.8% |
| Pneumonia |
8.7% |
| Death |
7.6% |
| Weight Decreased |
6.8% |
| Renal Failure Acute |
5.7% |
| Neutropenia |
5.3% |
| Fatigue |
4.9% |
| Nausea |
4.9% |
| Pain |
4.9% |
| Pulmonary Embolism |
4.6% |
| Weight Increased |
4.6% |
| Wrong Technique In Drug Usage Process |
4.2% |
| Urinary Retention |
3.8% |
| Anaemia |
3.4% |
| Somnolence |
3.4% |
| Thrombocytopenia |
3.4% |
| Oedema Peripheral |
3.0% |
| Respiratory Failure |
3.0% |
| Rhabdomyolysis |
3.0% |
| Aspartate Aminotransferase Increased |
2.7% |
|
| Interacting |
| Pain |
25.3% |
| Product Used For Unknown Indication |
23.0% |
| Insomnia |
6.9% |
| Neuralgia |
5.7% |
| Musculoskeletal Pain |
4.6% |
| Neck Pain |
4.6% |
| Hypertension |
3.4% |
| Substance Use |
3.4% |
| Abdominal Discomfort |
2.3% |
| Anxiety |
2.3% |
| Blood Pressure Abnormal |
2.3% |
| Depression |
2.3% |
| Intervertebral Disc Protrusion |
2.3% |
| Lumbar Spinal Stenosis |
2.3% |
| Pulmonary Tuberculosis |
2.3% |
| Spinal Osteoarthritis |
2.3% |
| Accidental Overdose |
1.1% |
| Nerve Injury |
1.1% |
| Smoking Cessation Therapy |
1.1% |
| Tobacco Abuse |
1.1% |
|
| Alcohol Interaction |
10.5% |
| Pain |
10.5% |
| Rash |
10.5% |
| Somnolence |
10.5% |
| Uterine Disorder |
10.5% |
| Wrong Technique In Drug Usage Process |
10.5% |
| Drug Level Above Therapeutic |
5.3% |
| Peripheral Vascular Disorder |
5.3% |
| Pulmonary Embolism |
5.3% |
| Speech Disorder |
5.3% |
| Tinnitus |
5.3% |
| Toxicity To Various Agents |
5.3% |
| Tremor |
5.3% |
|
